The use of recombinant human growth hormone in patients with Mucopolysaccharidoses and growth hormone deficiency: a case series

Abstract Background The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant human growth hormone in this selecte...

Full description

Bibliographic Details
Main Authors: A. Cattoni, S. Motta, N. Masera, S. Gasperini, A. Rovelli, R. Parini
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Italian Journal of Pediatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13052-019-0691-1